Home > Products > FGF2 & VEGF
> Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (scIgG)
Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (scIgG) (CAT#: SCIGG-160)
Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-FGF2 and anti-VEGF IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Hepatocellular cancer (HCC); Breast cancer; Colon cancer; Lung cancer; Glioma cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (scIgG) (SCIGG-160). Click the button below to contact us or submit your feedback about this product.